Cargando…
Genetic Markers Used for Risk Stratification in Multiple Myeloma
While no specific genetic markers are required in the diagnosis of multiple myeloma (MM), multiple genetic abnormalities and gene signatures are used in disease prognostication and risk stratification. This is particularly important for the adequate identification of the high-risk MM group, which do...
Autores principales: | Segges, Priscilla, Braggio, Esteban |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335595/ https://www.ncbi.nlm.nih.gov/pubmed/22567368 http://dx.doi.org/10.4061/2011/798089 |
Ejemplares similares
-
Genetic aberrations in multiple myeloma characterized by cIg-FISH: a
Brazilian context
por: Segges, P., et al.
Publicado: (2016) -
Risk Stratification and Treatment in Smoldering Multiple Myeloma
por: Lussier, Tyler, et al.
Publicado: (2021) -
Risk Stratification in Multiple Myeloma: Putting the Pieces Together
por: Mayo, Angela, et al.
Publicado: (2016) -
Multiple Myeloma: Risk Stratification and Toxicity Management
por: Richards, Tiffany, et al.
Publicado: (2018) -
The RAG Model: A New Paradigm for Genetic Risk Stratification in Multiple Myeloma
por: Prideaux, Steven M., et al.
Publicado: (2014)